Hyperfibrinogenemia as a Poor Prognostic Indicator in Myelodysplastic Syndrome

BACKGROUND: Myelodysplastic syndrome (MDS) is a group of heterogeneous myeloid clonal diseases originating from hematopoietic stem cells. It has been demonstrated that fibrinogen (FIB) is associated with disease risk in several cancer types. Coagulation and fibrinolysis problems are widespread in MD...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Cong, Gong, Shengping, Wu, An, Niu, Tingting, Wu, Ningning, Zhang, Yi, Ouyang, Guifang, Mu, Qitian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176632/
https://www.ncbi.nlm.nih.gov/pubmed/35693118
http://dx.doi.org/10.2147/CMAR.S363568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176632/
https://www.ncbi.nlm.nih.gov/pubmed/35693118
http://dx.doi.org/10.2147/CMAR.S363568

Ejemplares similares